Delivery Order SPE2DB20D3505-SPE2DB24FT3H4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,415.77 firm fixed price delivery order is for the pharmaceutical product Ozempic, a medication used to manage diabetes. The contract has an ultimate completion date of October 12, 2023 and was awarded on October 11, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic, a medication used to treat diabetes. The $5,126.02 fixed-price contract has an ultimate completion date of December 29, 2023. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., the parent company, which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $1,312.64 firm fixed-price delivery order is for the supply of Ozempic, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of May 13, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $10,449.36 delivery order contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a prescription medication used for the treatment of diabetes. The contract has a period of performance through December 7, 2023 and is a firm fixed-price delivery order. This award is not set aside for any particular business category. AmerisourceBergen Drug Corp, as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,421.42, is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. This is a firm fixed-price delivery order contract with an ultimate completion date of August 16, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the...
- This federal contract award, valued at $14,581.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ozempic, a diabetes medication, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The Delivery Order contract, valued at $3,870.01, is for the procurement of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract has an ultimate completion date of December 7, 2023 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $46,534.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used for diabetes management. This is a firm-fixed-price delivery order with an ultimate completion date of August 29, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $3,955.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for diabetes management. The contract has a completion date of May 7, 2024 and is a firm fixed-price delivery order. This award is not set-aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,741.62 delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a prescription medication. The contract has a firm fixed-price pricing type and an ultimate completion date of May 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FT3H4Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,459.56, is for the delivery of Ozempic, a prescription medication used to treat diabetes. The award is a Firm Fixed Price Delivery Order with a completion date of November 9, 2023. This contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical, valued up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and other federal healthcare programs. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/8/23 |